Diepolder HM[Author] - Search Results

Year	Number of Results
1994	2
1995	4
1996	2
1997	2
1998	3
1999	4
2000	3
2001	2
2002	2
2003	5
2004	3
2005	4
2006	3
2007	3
2008	4
2009	3
2010	2
2011	2
2013	1
2014	3
2024	0

1

Can specific heterologous immunity boost hepatitis B vaccine responses?

Diepolder HM. Diepolder HM. J Infect Dis. 2008 Aug 1;198(3):297-8. doi: 10.1086/589721. J Infect Dis. 2008. PMID: 18544036 No abstract available.

2

Immunopathogenesis of HCV infection.

Diepolder HM, Hoffmann RM, Gerlach JT, Zachoval R, Jung MC, Pape GR. Diepolder HM, et al. Curr Stud Hematol Blood Transfus. 1998;(62):135-51. doi: 10.1159/000060476. Curr Stud Hematol Blood Transfus. 1998. PMID: 9507808 Review. No abstract available.

3

T cell recognition of hepatitis B and C viral antigens.

Jung MC, Diepolder HM, Pape GR. Jung MC, et al. Among authors: diepolder hm. Eur J Clin Invest. 1994 Oct;24(10):641-50. doi: 10.1111/j.1365-2362.1994.tb01055.x. Eur J Clin Invest. 1994. PMID: 7531642 Review.

4

The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.

Diepolder HM, Zachoval R, Hoffmann RM, Jung MC, Gerlach T, Pape GR. Diepolder HM, et al. J Mol Med (Berl). 1996 Oct;74(10):583-8. doi: 10.1007/s001090050062. J Mol Med (Berl). 1996. PMID: 8912179 Review.

5

Interferon-alpha for hepatitis C: antiviral or immunotherapy?

Diepolder HM. Diepolder HM. J Hepatol. 2004 Jun;40(6):1030-1. doi: 10.1016/j.jhep.2004.04.002. J Hepatol. 2004. PMID: 15158347 Review. No abstract available.

6

New insights into the immunopathogenesis of chronic hepatitis C.

Diepolder HM. Diepolder HM. Antiviral Res. 2009 Jun;82(3):103-9. doi: 10.1016/j.antiviral.2009.02.203. Epub 2009 Mar 11. Antiviral Res. 2009. PMID: 19428600 Review.

7

The role of interleukin-22 in hepatitis C virus infection.

Dambacher J, Beigel F, Zitzmann K, Heeg MH, Göke B, Diepolder HM, Auernhammer CJ, Brand S. Dambacher J, et al. Among authors: diepolder hm. Cytokine. 2008 Mar;41(3):209-16. doi: 10.1016/j.cyto.2007.11.016. Epub 2008 Jan 11. Cytokine. 2008. PMID: 18191408

8

HLA and hepatitis B infection.

Diepolder HM, Jung MC, Albert E, Hoffmann RM, Zachoval R, Pape GR. Diepolder HM, et al. Lancet. 1994 Dec 24-31;344(8939-8940):1772-3. doi: 10.1016/s0140-6736(94)92912-2. Lancet. 1994. PMID: 7864991 No abstract available.

9

Clearance of HBV markers and HCC risk: who is safe?

Diepolder HM. Diepolder HM. Gut. 2014 Oct;63(10):1532-3. doi: 10.1136/gutjnl-2013-306317. Epub 2014 Jan 7. Gut. 2014. PMID: 24398880 No abstract available.

10

The role of the novel Th17 cytokine IL-26 in intestinal inflammation.

Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S. Dambacher J, et al. Among authors: diepolder hm. Gut. 2009 Sep;58(9):1207-17. doi: 10.1136/gut.2007.130112. Epub 2008 May 15. Gut. 2009. PMID: 18483078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year